In vivo electroporation: the key to unlocking the power of DNA-encoded vaccines and monoclonal antibodies
Cell Gene Therapy Insights 2019; 5(S1), 21-25.
Published: 4 February 2019
Trevor Smith is a molecular and cellular immunologist, whose research focuses upon the delivery of drugs against infectious disease and oncology targets. He is the lead or co-author of over 30 research papers across multiple fields. Dr Smith heads a preclinical research team developing DNA-based prophylactics and therapeutics at Inovio Pharmaceuticals in San Diego, California. He received his Bachelor degree in Biochemistry and Immunology from King’s College London, and completed his PhD studies at the National Heart and Lung Institute, Imperial College London. Dr Smith was the recipient of postdoctoral fellowships at the Scripps Research Institute in La Jolla, California.